Shares of German biotechnology firm CureVac BV soared as much as 222% after their Nasdaq debut on Friday, in the first stock market opening of a company developing a potential vaccine to combat the novel coronavirus.
from Top Business News- News18.com
Read The Rest:timesnownews...
from Top Business News- News18.com
Read The Rest:timesnownews...
COVID-19 vaccine developer CureVac shares more than triple after U.S. debut
Reviewed by Team Exprssnews
on
August 14, 2020
Rating:
No comments: